@Article{Grabowski2005,
journal="Przewodnik Lekarza/Guide for GPs",
issn="1505-8409",
year="2005",
title="Angiotensin converting enzyme inhibitors or angiotensin antagonists in diabetic nephropathy",
abstract="Diabetic nephropathy occurs is the single leading cause of end-stage renal disease. Intensive diabetes management has been shown in large prospective randomized studies to delay the onset of microalbuminuria and the progression of micro- to macroalbuminuria. In the treatment of both micro- and macroalbuminuria, either angiotensin converting enzyme inhibitors or angiotensin II antagonist should be used except during pregnancy.",
author="Grabowski, Marcin
and Filipiak, Krzysztof J.
and Opolski, Grzegorz",
pages="88--92",
url="https://www.termedia.pl/Angiotensin-converting-enzyme-inhibitors-or-angiotensin-antagonists-in-diabetic-nephropathy,8,4014,1,1.html"
}